BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12433833)

  • 1. Dance band on the Titanic: biomechanical signaling in cardiac hypertrophy.
    Sussman MA; McCulloch A; Borg TK
    Circ Res; 2002 Nov; 91(10):888-98. PubMed ID: 12433833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extracellular matrix and the cytoskeleton in heart hypertrophy and failure.
    Jane-Lise S; Corda S; Chassagne C; Rappaport L
    Heart Fail Rev; 2000 Oct; 5(3):239-50. PubMed ID: 16228907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II, adhesion, and cardiac fibrosis.
    Schnee JM; Hsueh WA
    Cardiovasc Res; 2000 May; 46(2):264-8. PubMed ID: 10773230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta1 integrins participate in the hypertrophic response of rat ventricular myocytes.
    Ross RS; Pham C; Shai SY; Goldhaber JI; Fenczik C; Glembotski CC; Ginsberg MH; Loftus JC
    Circ Res; 1998 Jun; 82(11):1160-72. PubMed ID: 9633916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium sensing receptor promotes cardiac fibroblast proliferation and extracellular matrix secretion.
    Zhang X; Zhang T; Wu J; Yu X; Zheng D; Yang F; Li T; Wang L; Zhao Y; Dong S; Zhong X; Fu S; Xu CQ; Lu F; Zhang WH
    Cell Physiol Biochem; 2014; 33(3):557-68. PubMed ID: 24603056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast-mediated pathways in cardiac hypertrophy.
    Fujiu K; Nagai R
    J Mol Cell Cardiol; 2014 May; 70():64-73. PubMed ID: 24492068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction systems and atrial fibrillation.
    Goette A; Lendeckel U; Klein HU
    Cardiovasc Res; 2002 May; 54(2):247-58. PubMed ID: 12062330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biochemical response of the heart to hypertension and exercise.
    Wakatsuki T; Schlessinger J; Elson EL
    Trends Biochem Sci; 2004 Nov; 29(11):609-17. PubMed ID: 15501680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor.
    Thomas WG; Brandenburger Y; Autelitano DJ; Pham T; Qian H; Hannan RD
    Circ Res; 2002 Feb; 90(2):135-42. PubMed ID: 11834705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase cascades in the regulation of cardiac hypertrophy.
    Dorn GW; Force T
    J Clin Invest; 2005 Mar; 115(3):527-37. PubMed ID: 15765134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin signalling: the tug-of-war in heart hypertrophy.
    Brancaccio M; Hirsch E; Notte A; Selvetella G; Lembo G; Tarone G
    Cardiovasc Res; 2006 Jun; 70(3):422-33. PubMed ID: 16466704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtubules in cardiac hypertrophy: a mechanical role in decompensation?
    ter Keurs HE
    Circ Res; 1998 Apr; 82(7):828-31. PubMed ID: 9562443
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
    Creemers EE; Pinto YM
    Cardiovasc Res; 2011 Feb; 89(2):265-72. PubMed ID: 20880837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor in myocardial hypertrophy and ischaemia--an anti-apoptotic perspective.
    Sack MN; Smith RM; Opie LH
    Cardiovasc Res; 2000 Feb; 45(3):688-95. PubMed ID: 10728390
    [No Abstract]   [Full Text] [Related]  

  • 15. Negative regulators of cardiac hypertrophy.
    Hardt SE; Sadoshima J
    Cardiovasc Res; 2004 Aug; 63(3):500-9. PubMed ID: 15276475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
    Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic signaling pathways that regulate cardiac hypertrophy.
    Molkentin JD; Dorn GW
    Annu Rev Physiol; 2001; 63():391-426. PubMed ID: 11181961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-infarction myocardial remodelling: why does it happen?
    Francis GS; Chu C
    Eur Heart J; 1995 Dec; 16 Suppl N():31-6. PubMed ID: 8682059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
    Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
    Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.
    Guo D; Kassiri Z; Basu R; Chow FL; Kandalam V; Damilano F; Liang W; Izumo S; Hirsch E; Penninger JM; Backx PH; Oudit GY
    Circ Res; 2010 Nov; 107(10):1275-89. PubMed ID: 20847309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.